Caribou Biosciences (CRBU) Return on Sales (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Return on Sales data on file, last reported at 0.12% in Q1 2026.

• On a quarterly basis, Return on Sales rose 7.0% year-over-year to 0.12% in Q1 2026; TTM through Mar 2026 was 0.12%, a 10.0% increase from a year earlier, with the FY2025 full-year figure at 0.13%, up 2.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.12%, down from 0.07% in the prior quarter.
• Over the last five years, Return on Sales for CRBU reached as high as 0.01% in Q3 2023 and fell as low as 0.38% in Q3 2024.
• Historically, Return on Sales has averaged 0.16% across 5 years, with a median of 0.16% in 2022.
• Across the five-year window, Return on Sales tumbled 36 bps in 2024 and grew 23 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.08% in 2022, then fell by 25 bps to 0.11% in 2023, then tumbled by 84 bps to 0.19% in 2024, then soared by 62 bps to 0.07% in 2025, then tumbled by 60 bps to 0.12% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.12% in Q1 2026, 0.07% in Q4 2025, and 0.15% in Q3 2025.